Frazer Lab Department of Pediatrics, Genome Information Sciences

  • pic1
  • pic4
  • pic2
  • pic3
  • pic4

Welcome to the Frazer Lab and the Division of Genome Information Sciences

The Division of Genome Information Sciences was established in the fall of 2009 and is led by Dr. Kelly Frazer in the UC San Diego School of Medicine’s Department of Pediatrics. Located in the Moores UCSD Cancer Center, the members of the division work closely with physicians in the Department of Pediatrics, the Moores UCSD Cancer Center, and Rady Children’s Hospital. The division collaborates frequently with the university’s Institute for Genomic Science and the Clinical and Translational Research Institute.

About Us

    An important research focus of this division is to use genomic information to understand disease predisposition, progression and patients' response to drugs. For this, we develop genomic and bioinformatics approaches to identify new biomarkers or candidate drug targets. Our expertise is diverse, spanning from human genetics and functional genomics, to cancer genomics and clinical sequencing. Our main mission is to accelerate the translation of genomic discoveries into the clinic. Members of the division collaborate closely with clinical investigators, in particular via the Clinical and Translational Research Institute.

    Cardiogenetics Study at UCSD

    Help us learn more about the genetic factors that predispose to heart disease.

    Enroll today!

    Click banner below for more information.


    The division main areas of research are Genetic and Functional genomics: we identify both rare and common genetic variants that are associated with a variety human diseases. We then annotate these variants, in particular the ones that impact transcriptional regulation, in order to explain their association with the disease.

    Cancer Genomics: We look at the molecular profile of tumors of a variety of cancer types to identify novel therapeutic targets, improve disease classification, and understand carcinogenesis and cancer progression. In particular, we develop approaches to integrate both genetic, epigenetic and expression information.

External Resources: